• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Mumbai, Aug. 29

Pharmaceutical company Abbott India Ltd’s board will meet on September 5 to consider a proposal for buyback of a portion of fully paid equity shares of the company at a price to be determined by the board, not exceeding Rs 650 per equity share, the company told the Bombay Stock Exchange. Abbott shares closed at Rs 571.30, up 8.56 per cent, on the BSE.

— Our Bureau

More Stories on : Buyback | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Volvo Cars to launch S80, XC90

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line